Return On Asset ratio Analysis of Inhibikase Therapeutics Inc - Deep Dive


Latest FY ROA
Period Ending - Dec-23

-131.87


Very Poor ROA
Period Ending - Dec-22
-72401.10

Very Poor ROA
Growth
99.82 %
Trailing Twelve Months ROA
Period Ending - Dec-23

-102.17


Very Poor ROA
Most recent Quarter ROA
Period Ending - Mar-24

-42.01


Very Poor ROA
ROA Analysis of Inhibikase Therapeutics Inc
ROA Ratio of Inhibikase Therapeutics Inc with value of -102.17 means poor return on Assets in trailing twelve months.
ROA Ratio of Inhibikase Therapeutics Inc with value of -42.01 means poor return on Assets in latest Quarter ending on Mar-24.
ROA Ratio of IKT rose handsomely by 99.82 % this year.
ROA Ratio with value of -131.87 was highest in Year Dec-23 in last Five Years.
ROA Ratio with value of -72401.10 was lowest in Year Dec-22 in last Five Years.
Latest ROA Ratio with value of -131.87 is Greater than Average ROA of -28314.76 in last five years.
ROA of Inhibikase Therapeutics Inc is negative because of negative Income in last Financial Year , last Quarter and also in last twelve Months.
Other ROA Related Info of IKT that may interest you.
Inhibikase Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
IKT1.841.81 1.66 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Return On Asset
The return on assets (ROA) is a commonly used profitability ratio that shows how effectively a company uses its assets to generate profit.   more ..
Return On Asset Formula

ROA Related Ratios
ReturnOnEquityAssetTurnoverRatio

Tsr Profitability Index
Poor Profitability Stock
FY - Historical Return On Asset of Inhibikase Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
ROA-131.87-72401.10-34815.31-19265.03-14960.48-75.620
Change99.82 %-107.96 %-80.72 %-28.77 %-19684.04 %
You are view first 7 Records. Log in to view all 8 in Premium view
FY Chart of Return On Asset of Inhibikase Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)